Early Phase Cancer Immunotherapy

This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.

Verwandte Artikel

Download
PDF
Early Phase Cancer Immunotherapy Sandip Pravin Patel, Razelle Kurzrock

149,79 €*